We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$561M
Cap. Flow
-$5.26M
Cap. Flow %
-0.29%
Top 10 Hldgs %
16.32%
Holding
823
New
371
Increased
67
Reduced
65
Closed
283

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$29.9M
2
EXAS
Exact Sciences
EXAS
+$12.2M
3
FIVE icon
Five Below
FIVE
+$6.65M
4
KSS icon
Kohl's
KSS
+$6.63M
5
BKS
Barnes & Noble
BKS
+$5.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 84.92%
2 Healthcare 4.2%
3 Consumer Discretionary 2.61%
4 Technology 1.71%
5 Energy 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DORM icon
351
Dorman Products
DORM
$3.72B
$1.02M 0.06%
+11,600
New +$1.01M
TNDM icon
352
CALL
Tandem Diabetes Care
TNDM
$1.13B
$1.02M 0.06%
16,000
-87,700
-85% -$4.61M
GE icon
353
GE Aerospace
GE
$319B
$999K 0.06%
20,064
+4,414
+28% +$208K
STNE icon
354
StoneCo
STNE
$2.23B
$999K 0.06%
+24,300
New +$660K
UFS
355
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
$993K 0.05%
+20,000
New +$951K
YEXT icon
356
CALL
Yext
YEXT
$632M
$984K 0.05%
+45,000
New +$816K
ITCI
357
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$975K 0.05%
+80,000
New +$1.02M
SFLY
358
DELISTED
Shutterfly, Inc.
SFLY
$975K 0.05%
24,000
+9,400
+64% +$413K
AUPH icon
359
CALL
Aurinia Pharmaceuticals
AUPH
$2.15B
$974K 0.05%
+150,000
New +$995K
NOK icon
360
Nokia
NOK
$55.1B
$972K 0.05%
+170,000
New +$1.04M
TZOO icon
361
Travelzoo
TZOO
$57.3M
$965K 0.05%
+72,000
New +$954K
XLE icon
362
State Street Energy Select Sector SPDR ETF
XLE
$43.3B
$965K 0.05%
+29,200
New +$938K
IRWD icon
363
Ironwood Pharmaceuticals
IRWD
$671M
$962K 0.05%
101,490
-137,310
-58% -$1.53M
LUMN icon
364
CALL
Lumen
LUMN
$7.04B
$959K 0.05%
80,000
-12,000
-13% -$167K
ACAD icon
365
CALL
Acadia Pharmaceuticals
ACAD
$4.61B
$940K 0.05%
+35,000
New +$817K
ACAD icon
366
PUT
Acadia Pharmaceuticals
ACAD
$4.61B
$940K 0.05%
+35,000
New +$817K
KTOS icon
367
Kratos Defense & Security Solutions
KTOS
$8.94B
$938K 0.05%
60,000
+45,600
+317% +$717K
TDS icon
368
Telephone and Data Systems
TDS
$4.35B
$923K 0.05%
+30,000
New +$1.02M
WBC
369
DELISTED
WABCO HOLDINGS INC.
WBC
$923K 0.05%
+7,000
New +$862K
LNW
370
PUT
DELISTED
Light & Wonder
LNW
$919K 0.05%
45,000
-60,000
-57% -$1.43M
WBT
371
PUT
DELISTED
Welbilt, Inc.
WBT
$918K 0.05%
+56,000
New +$817K
MNTV
372
DELISTED
Momentive Global Inc. Common Stock
MNTV
$910K 0.05%
+50,000
New +$704K
IMMU
373
PUT
DELISTED
Immunomedics Inc
IMMU
$910K 0.05%
47,400
HRTX icon
374
Heron Therapeutics
HRTX
$59.6M
$909K 0.05%
+37,200
New +$974K
TME icon
375
Tencent Music
TME
$12.9B
$905K 0.05%
+50,000
New +$798K

Similar funds

Caption Management's Q1 2019 Portfolio in Review

As of Q1 2019, Caption Management held 823 positions worth $1.81B, up 45% from $1.25B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management's Q1 2019 filing shows 371 new, 67 increased, 65 reduced and 283 closed positions. Its largest new stake was Tapestry: 580,000 shares worth $18.8M. The largest sale was Caesars Entertainment, an estimated $29.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Caption Management's largest Q1 2019 buy was Tapestry: 580,000 shares worth $18.8M.
  • Caption Management added most to Bristol-Myers Squibb in Q1 2019, an estimated $13.2M increase.
  • Caption Management's biggest Q1 2019 reduction was Somnigroup International, cutting an estimated $4.33M.
  • Caption Management fully exited Caesars Entertainment in Q1 2019, selling an estimated $29.9M.
  • Caption Management's ten largest holdings make up 16% of its $1.81B portfolio in Q1 2019.
  • Caption Management opened 371 new positions and closed 283 in Q1 2019.
  • Caption Management's portfolio value rose 45% quarter-over-quarter to $1.81B.

Based on Caption Management's 13F filing for Q1 2019, filed 14 May 2019.